Karyopharm Therapeutics Inc. - Common Stock (KPTI)

7.8450
+0.3750 (5.02%)
NASDAQ· Last Trade: May 20th, 12:51 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026